Skip to content

Role of Homoeopathy in the treatment of Fibromyalgia using Synthetic Repertory

Effect of Individualized Homoeopathic medicines using the Synthetic Repertory in the management of Fibromyalgia a prospective single arm study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094494
Enrollment
35
Registered
2025-09-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M797- Fibromyalgia

Interventions

Intervention1: Homoeopathic medicine: Pill form of administration Oral route of administration 30 pill size Centesimal scale First dose after case taking repetition of dose according to follow up Inte

Sponsors

Bakson Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age group 18 to 59 years irrespective of their sex socioeconomic status and occupation Participants diagnosed with fibromyalgia according to the american college of rheumatology 2016 criteria Participants who have willingly joined the study and signed the written informed consent form Participants currently taking medications from other systems of medicine will be enrolled only after completing a two-week washout period provided they are willing to discontinue such medicines The occasional use of mild painkillers example paracetamol will be permitted The number and frequency of painkiller doses will be carefully documented at baseline and monitored throughout the study for comparison before and after treatment

Exclusion criteria

Exclusion criteria: Participants diagnosed with other chronic pain syndromes Participants diagnosed with hypothyroidism Participants with severe alcohol dependence Presence of severe psychiatric illness Pregnant or lactating women Participants diagnosed with other immunocompromised conditions and autoimmune diseases Participant on medications that cannot be safely stopped or tapered without the authorized physician supervision or where such supervision is unavailable.

Design outcomes

Primary

MeasureTime frame
To assess the changes in pain fatigue levels and sleep quality using Revised Fibromyalgia Impact Questionnaire before and after giving individualized Homoeopathic medicinesTimepoint: 16 months study 6 months enrolment 6 months follow up 2 months data analysis 2 months report writing Revised fibromyalgia impact questionnaire is used statistical data analysis done at baseline 3rd month and 6th month

Secondary

MeasureTime frame
To assess the change in stress levels among participants receiving individualized Homoeopathic treatment using the Perceived Stress ScaleTimepoint: 16 months study 6 months enrolment 6 months follow up 2 months data analysis 2 months report writing Revised fibromyalgia impact questionnaire is used statistical data analysis done at baseline 3rd month and 6th month;To evaluate the changes in quality of life in fibromyalgia participants following individualized homoeopathic management, measured by the EQ 5D 5L EuroQol 5 Dimension 5 Level questionnaire.Timepoint: 16 months study 6 months enrolment 6 months follow up 2 months data analysis 2 months report writing Revised fibromyalgia impact questionnaire is used statistical data analysis done at baseline 3rd month and 6th month

Countries

India

Contacts

Public ContactDr Aditi Goyal

Bakson homoeopathic medical college and hospital

drshailjaupadhyay22@gmail.com8447753501

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026